Cyclo Therapeutics, Inc. Quarterly Costs and Expenses in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cyclo Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q2 2024.
  • Cyclo Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $5.75M, a 21.5% increase year-over-year.
  • Cyclo Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $22.2M, a 13.3% increase year-over-year.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2023 was $21M, a 24.8% increase from 2022.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2022 was $16.9M, a 6.19% increase from 2021.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2021 was $15.9M, a 60.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $22.2M $5.75M +$1.02M +21.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $21.2M $5.31M +$162K +3.15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $21M $5.9M +$869K +17.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $20.2M $5.26M +$562K +12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $19.6M $4.73M +$732K +18.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $18.9M $5.15M +$2.02M +64.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $16.9M $5.03M +$1.65M +48.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $15.2M $4.7M +$438K +10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $14.8M $4M +$159K +4.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $14.6M $3.13M -$1.27M -28.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $15.9M $3.38M +$551K +19.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $15.3M $4.26M +$2.6M +157% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $12.7M $3.84M +$1.43M +59.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $11.3M $4.4M +$1.43M +48.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $9.86M $2.83M -$38.2K -1.33% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $9.9M $1.66M -$256K -13.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $10.2M $2.41M +$768K +46.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $9.39M $2.97M +$839K +39.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $8.55M $2.87M +$1.26M +78.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $7.29M $1.91M +$900K +88.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $6.39M $1.64M -$776 -0.05% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $6.39M $2.13M +$1.12M +110% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $5.28M $1.61M +$53.9K +3.47% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $5.22M $1.01M +$136K +15.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $5.09M $1.64M +$290K +21.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $4.8M $1.01M -$283K -21.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $5.08M $1.55M +$231K +17.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $4.85M $878K -$1.01M -53.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $5.86M $1.35M -$97.9K -6.74% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $5.96M $1.3M +$250K +23.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $5.71M $1.32M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $1.89M +$914K +93.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $1.45M +$719K +98.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $1.05M +$490K +88.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q3 2015 $975K +$390K +66.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $733K +$346K +89.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $556K +$154K +38.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 $585K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $387K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $402K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2012 $1M $186K -$91.4K -33% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $1.09M $207K -$121K -36.9% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $1.21M $366K +$107K +41.3% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-21
Q4 2011 $1.11M $241K Oct 1, 2011 Dec 31, 2011 10-K 2012-03-16
Q3 2011 $277K +$66.8K +31.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $329K +$199K +154% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $259K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 $211K Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-02-23
Q2 2010 $129K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.